SME · NSE EmergeListed

ABH Healthcare Ltd. IPO: dates, price band, lot size, objects of the issue

Get analyst updates on this IPO

Analyst updates come by email.

What changed since listing, from SEBI-registered research analysts.

By continuing you agree to the Terms and Privacy policy

Updated Tue 17 Nov 2026, 10:51 am IST · Source: Prospectus

Bid dates
Mon 24 Aug 2026 to Thu 27 Aug 2026
Listing date
Tue 1 Sep 2026
Issue price
₹102 per share

Listed on NSE on Tue 1 Sep 2026.

Listing price ₹99

Opening price on NSE on the listing day (ipocentral.in, as of Tue 17 Nov 2026)

This page is now frozen. Facts stay as filed; the quote is on the exchange.

Key facts

Issue price
₹102 per share
Prospectus, page 2
Lot size
Not stated in the prospectus
Prospectus
Lot amount at the upper band
Not stated in the prospectus
Prospectus
Issue size at the upper band
₹34.98 crore
Fresh issue
₹34.98 crore
Prospectus, page 1
Offer for sale
None
Prospectus, page 1
Bid dates
Mon 24 Aug 2026 to Thu 27 Aug 2026
Prospectus, page 1
Listing date
Tue 1 Sep 2026
groww.in, ipocentral.in and ipowatch.in, as of Tue 17 Nov 2026
Anchor lock-in ends
Not stated in the prospectus
Prospectus
Risk factors
76
Prospectus, page 59

Timeline (IST)

  1. OpensMon 24 Aug 2026, 10:00 am IST confirmedProspectus, page 1
  2. ClosesThu 27 Aug 2026 confirmedProspectus, page 1
  3. UPI mandate cut-offNot stated in the prospectus Prospectus
  4. AllotmentFri 28 Aug 2026 by T+3 schedule
  5. Refund and unblockMon 31 Aug 2026 by T+3 schedule
  6. Shares to dematMon 31 Aug 2026 by T+3 schedule
  7. ListingTue 1 Sep 2026 confirmedgroww.in, ipocentral.in and ipowatch.in, as of Tue 17 Nov 2026

Objects of the issue

ObjectAmount
Repayment/prepayment, in part or full, of certain of our borrowings₹17.00 crore
Funding our working capital requirements₹5.00 crore
Funding inorganic growth through unidentified acquisitions and general corporate purposes₹8.62 crore
Total₹30.62 crore

Prospectus, page 86

Company and promoters

As described in the prospectus

Our core focus is on providing specialised tertiary medical care in Tier 3 cities, within the state of Punjab while seeking to strike a balance between providing quality healthcare services and affordability.

Prospectus, page 125

Promoters

  • 3 individual promoters

Prospectus, page 172

Shareholding

HoldingBefore the issueAfter the issue
Promoters and promoter group100.00%Not stated in the prospectus
Public0.00%Not stated in the prospectus

Prospectus, page 80

Financials (restated)

Item31.03.202631.03.202531.03.2024
Revenue from operations₹52.51 crore₹49.27 crore₹41.38 crore
Profit after tax₹5.64 crore₹5.35 crore₹1.66 crore
Net worth₹17.34 crore₹11.69 crore₹6.35 crore
Total borrowingsNot stated in the prospectusNot stated in the prospectusNot stated in the prospectus

Prospectus, page 65

SME issue facts

  • Fresh issue of 34,29,600 Equity Shares of face value of ₹ 10/- each for cash at a price of ₹ 102 /- per Equity Share (Prospectus, page 267)
  • aggregating to maximum ₹ 3,498.19 lakhs (“the Issue”) by our Company. (Prospectus, page 267)
  • The Issue is being made by way of 100% Book Built method. (Prospectus, page 267)
  • 1,72,800 Equity Shares of face value of ₹10/- each (Prospectus, page 267)
  • 5.04% of the Issue size (Prospectus, page 267)
  • 1,99,200 Equity Shares of face value of ₹10 each (Prospectus, page 267)
  • Not more than 50% of the Net Issue being available for allocation to QIB Bidders. (Prospectus, page 267)
  • 15,28,800 Equity Shares of face value of ₹ 10 each available for allocation or Issue less allocation to QIB Bidders and IIBs (Prospectus, page 267)
  • Not less than 15% of the Net Issue (Prospectus, page 267)
  • 15,28,800 Equity Shares of face value of ₹ 10 each available for allocation or Issue less allocation to QIB Bidders and Non- Institutional Bidders (Prospectus, page 267)
  • Not less than 35% of the Net Issue. (Prospectus, page 267)
  • Firm Allotment (Prospectus, page 267)
  • Trading Lot 1200 Equity Shares of face value of ₹10/- each, however, the Market Maker may accept odd lots if any in the market as required under the SEBI ICDR Regulations (Prospectus, page 268)
  • Such number of Equity Shares in two lots so that the Bid Amount exceeds ₹ 2.00 lakhs (Prospectus, page 268)

Peer comparison (as in the Prospectus)

Name of the companyConsolidated/ StandaloneCurrent Market Price (CMP)Revenue from Operations (₹ in Lakhs)EPS (in ₹) BasicEPS (in ₹) DilutedP/E RatioPAT margin (%)RONW (%)NAV (Per Share)Face Value (in ₹)Market cap to Revenue from operation
ABH Healthcare LimitedConsolidated102.00*5,250.697.057.0514.4710.7439.0721.5810.002.22
Sangani Hospitals LimitedConsolidated51.3510,695.812.172.1723.665.1716.2023.3010.000.69
Maitreya Medicare LimitedConsolidated118.954,484.99(3.64)(3.64)(32.68)(5.50)(8.10)42.6710.001.88
Asarfi Hospital LimitedConsolidated215.0017,350.298.478.4725.389.6018.6549.6210.002.65

Reproduced from the Prospectus, page 101; InsightPier adds no figures

Risk factors

76 total
  1. The company has a short operating history because it was set up to take over a promoter's hospital business (offer document page 30)
  2. Almost all revenue comes from a single hospital in Ferozepur, Punjab (offer document page 31)
  3. Dependence on third-party suppliers and contracts with insurers, administrators and government payers (offer document page 32)
  4. Issue money set aside for acquisitions not yet identified may be invested in businesses that do not last (offer document page 35)
  5. The registered office and hospital premises are not owned by the company (offer document page 35)

All 76 risk factors, pages 30 to 60

Offer document

Allotment and bids

Registrar to the issue: Bigshare Services Private Limited.

Allotment status was expected on the registrar's site from Fri 28 Aug 2026 and is not yet confirmed. Pick "ABH Healthcare Ltd." from the issue list there.

Subscription (final)

CategoryShares offeredShares bid forTimes subscribed
Overall––1.49×

ipocentral.in and ipowatch.in, as of Tue 17 Nov 2026

Research

Research reports on IPOs from SEBI-registered research analysts, published on InsightPier.

Research reports on IPOs from SEBI-registered research analysts